Mequinol
Solage (mequinol) is a small molecule pharmaceutical. Mequinol was first approved as Solage on 1999-12-10. It is used to treat lentigo in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area | MeSH |
|---|---|
| skin and connective tissue diseases | D017437 |
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Mequinol
+
Tretinoin
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| SOLAGE | Almirall | N-020922 DISCN | 1999-12-10 | 1 products |
Hide discontinued
Labels
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
No data
Clinical
Clinical Trials
58 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Pain | D010146 | EFO_0003843 | R52 | — | — | 1 | 5 | 2 | 8 |
| Anesthesia | D000758 | — | — | — | 2 | 2 | 4 | ||
| Hip osteoarthritis | D015207 | EFO_1000786 | M16 | — | 1 | 1 | 2 | — | 3 |
| Postoperative pain | D010149 | G89.18 | — | — | — | 2 | 1 | 3 | |
| Pulpitis | D011671 | EFO_1001139 | K04.0 | — | — | — | 1 | 2 | 3 |
| Local anesthesia | D000772 | — | 1 | 1 | 1 | — | 3 | ||
| Knee osteoarthritis | D020370 | EFO_0004616 | M17 | — | 1 | 1 | 1 | — | 2 |
| Nerve block | D009407 | — | — | — | 1 | 1 | 2 | ||
| Spinal anesthesia | D000775 | — | — | — | 2 | — | 2 | ||
| Hypertension | D006973 | EFO_0000537 | I10 | — | — | — | 2 | — | 2 |
Show 15 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Low back pain | D017116 | HP_0003419 | M54.5 | 1 | 1 | — | — | — | 1 |
| Intervertebral disc degeneration | D055959 | HP_0008419 | 1 | 1 | — | — | — | 1 | |
| Ischemic stroke | D000083242 | — | 1 | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hypotension | D007022 | EFO_0005251 | I95 | — | — | — | — | 1 | 1 |
| Anterior cruciate ligament injuries | D000070598 | — | — | — | — | 1 | 1 | ||
| Orthodontic anchorage procedures | D052280 | — | — | — | — | 1 | 1 | ||
| Bursitis | D002062 | EFO_1000941 | M71.9 | — | — | — | — | 1 | 1 |
| Edema | D004487 | R60.9 | — | — | — | — | 1 | 1 | |
| Trismus | D014313 | — | — | — | — | 1 | 1 | ||
| Chronic renal insufficiency | D051436 | N18 | — | — | — | — | 1 | 1 | |
| Neuromuscular blockade | D019148 | — | — | — | — | 1 | 1 | ||
| Vibration | D014732 | — | — | — | — | 1 | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | MEQUINOL |
| INN | mequinol |
| Description | P-methoxyphenol is a member of phenols and a member of methoxybenzenes. It has a role as a metabolite. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) | |
| Structure (InChI/SMILES or Protein Sequence) | COc1ccc(O)cc1 |
Identifiers
| PDB | — |
| CAS-ID | 150-76-5 |
| RxCUI | 15080 |
| ChEMBL ID | CHEMBL544 |
| ChEBI ID | 69441 |
| PubChem CID | 9015 |
| DrugBank | DB09516 |
| UNII ID | 6HT8U7K3AM (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 147 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
928 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more